Harrington KJ - Search Results

1

Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy.

Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. Spitzweg C, et al. Among authors: harrington kj. J Clin Endocrinol Metab. 2001 Jul;86(7):3327-35. doi: 10.1210/jcem.86.7.7641. J Clin Endocrinol Metab. 2001. PMID: 11443208 Review. No abstract available.

2

Transcriptional control: an essential component of cancer gene therapy strategies?

Harrington KJ, Linardakis E, Vile RG. Harrington KJ, et al. Adv Drug Deliv Rev. 2000 Nov 15;44(2-3):167-84. doi: 10.1016/s0169-409x(00)00093-4. Adv Drug Deliv Rev. 2000. PMID: 11072113 Review.

3

Cancer gene therapy: developments to 2000.

Bateman AR, Harrington KJ, Melcher AA, Vile RG. Bateman AR, et al. Among authors: harrington kj. Expert Opin Investig Drugs. 2000 Dec;9(12):2799-813. doi: 10.1517/13543784.9.12.2799. Expert Opin Investig Drugs. 2000. PMID: 11093354 Review.

4

Gene therapy for prostate cancer: current status and future prospects.

Harrington KJ, Spitzweg C, Bateman AR, Morris JC, Vile RG. Harrington KJ, et al. J Urol. 2001 Oct;166(4):1220-33. doi: 10.1016/s0022-5347(05)65742-4. J Urol. 2001. PMID: 11547047 Review.

5

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.

Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C. Scholz IV, et al. Among authors: harrington kj. Gene Ther. 2005 Feb;12(3):272-80. doi: 10.1038/sj.gt.3302410. Gene Ther. 2005. PMID: 15510175

6

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.

Mansfield DC, Kyula JN, Rosenfelder N, Chao-Chu J, Kramer-Marek G, Khan AA, Roulstone V, McLaughlin M, Melcher AA, Vile RG, Pandha HS, Khoo V, Harrington KJ. Mansfield DC, et al. Among authors: harrington kj. Gene Ther. 2016 Apr;23(4):357-68. doi: 10.1038/gt.2016.5. Epub 2016 Jan 27. Gene Ther. 2016. PMID: 26814609 Free PMC article.

7

Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.

Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ. Higuchi H, et al. Cancer Res. 2000 Nov 15;60(22):6396-402. Cancer Res. 2000. PMID: 11103804

8

Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy.

Hingorani M, White CL, Zaidi S, Merron A, Peerlinck I, Gore ME, Nutting CM, Pandha HS, Melcher AA, Vile RG, Vassaux G, Harrington KJ. Hingorani M, et al. Among authors: harrington kj. Clin Cancer Res. 2008 Aug 1;14(15):4915-24. doi: 10.1158/1078-0432.CCR-07-4049. Clin Cancer Res. 2008. PMID: 18676766

9

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.

Ahmed A, Jevremovic D, Suzuki K, Kottke T, Thompson J, Emery S, Harrington K, Bateman A, Vile R. Ahmed A, et al. Gene Ther. 2003 Sep;10(19):1663-71. doi: 10.1038/sj.gt.3302064. Gene Ther. 2003. PMID: 12923565

10

APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable.

Vile RG, Melcher A, Pandha H, Harrington KJ, Pulido JS. Vile RG, et al. Among authors: harrington kj. Clin Cancer Res. 2021 Jun 15;27(12):3280-3290. doi: 10.1158/1078-0432.CCR-20-1888. Epub 2021 Feb 8. Clin Cancer Res. 2021. PMID: 33558423 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page